Lassman, AB, Polley, MC, Iwamoto, FM
et al. (2023). PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
.
NEURO-ONCOLOGY, 25(Supplement_2), ii2-ii2. 10.1093/neuonc/noad137.005
Lassman, AB, Polley, MC, Iwamoto, FM et al. (2023). PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
. NEURO-ONCOLOGY, 25(Supplement_2), ii2-ii2. 10.1093/neuonc/noad137.005